近日，泰州金控发布江苏省战略性新兴产业母基金"泰州大健康先进制造产业专项母基金产业子基 金"和"泰州新材料产业专项母基金产业子基金"管理机构遴选公告。 泰州大健康先进制造产业专项母基金产业子基金总规模10亿元，旨在支持泰州市推动战略性新兴 产业集群融合发展，优化地方现代化产业体系布局。基金主要投资于化学药、生物药、中药、合成 生物、高端医疗器械等大健康产业方向等，以及江苏省"1650"产业体系、"51010"战略性新兴产业 集群、泰州"8+13+X"产业集群中与大健康先进制造相关的重点领域。 每日｜荐读 热文： 社会LP去哪了 热文： 购基金井喷，巨头们开始"买买买" 报告： 独角兽的"新双轮驱动"：《2025中国CVC影响力报告》发布 报告： 哪些LP在活跃出资？——《LP全景报告2024》发布 泰州新材料产业专项母基金规模10亿元，旨在支持泰州市推动战略性新兴产业集群融合发展，优 化地方现代化产业体系布局。基金主要投资于先进石化化工新材料、先进钢铁材料、先进有色金属 材料、高性能纤维及制品和复合材料、先进无机非金属材料产业方向等，以及江苏省"1650"产业 体系、"51010"战略性新兴产业集群、泰州"8 ...

5月26日，青岛国恩科技股份有限公司（以下简称：国恩股份 002768．SZ）发布公告称，公司于2025年5月26日召开董事会和监事 会，审议通过发行H股股票并在香港联交所主板挂牌上市的议案。公司计划通过发行境外上市外资股（H股）股票，打造国际化资本 运作平台，加快构建国内国际双循环格局。 根据公告披露，国恩股份本次拟发行的H股股数不超过本次发行后公司总股本的15％（超额配售权行使前），募集资金在扣除相关发 行费用后，将全部用于建设香港区域总部平台、科创研发投入、新增产能布局及战略性投资并购、补充运营资金等用途。本次发行 并上市尚需提交股东大会审议，并取得相关监管机构的备案、批准或核准。公司正积极推进相关工作，具体细节尚需进一步商讨。 另外值得注意的是，同在5月26日，国恩股份还发布了一则人事变动公告，公告显示，董事会近日收到董事张世德及独立董事刘树艳 的辞职报告。其中张世德因个人原因辞去董事职务，辞职后将继续在公司下属子公司任职；刘树艳也因个人原因辞去独立董事职 务，及在董事会各委员会的职务。辞职后，二人均未持有公司股份，且其辞职不会影响董事会的法定人数。 2025年一季度报显示，国恩股份今年一季度营收为4 ...

2025 年以来，大健康产业在技术突破、消费观念转变与政策引导的交织作用下，正经历深刻的结构性变革。从数字化健康管理工具的普及到个性 化服务模式的兴起，产业发展的底层逻辑持续重构。作为深耕大健康领域的参与者，中康晟兴始终以敏锐视角捕捉行业动态，为产业升级提供前 瞻性思考。 技术驱动下的服务模式创新 以人工智能、物联网为代表的新技术正重塑大健康服务生态。智能穿戴设备实现健康数据实时采集，远程医疗系统打破地域限制，数字化平台整 合健康管理全链条资源。这些技术不仅催生了精准营养定制、在线指导等新业态，更推动服务向 "预防 - 干预 - 跟踪"一体化延伸。中康晟兴相关 负责人指出："技术赋能正在打破传统服务边界，企业需构建'技术 + 场景 + 体验'的深度融合模式。" 健康消费升级催生价值重构 随着公众健康意识提升，消费需求从"疾病治疗"转向"全周期健康管理"。消费者对体重管理、睡眠改善、情绪调节等细分领域的个性化服务需求 显著增长，更注重服务的科学性与情感共鸣。例如，体重管理领域不再局限于单一产品供给，而是通过饮食规划、运动指导、心理干预等多维度 方案，为用户构建系统性健康管理体系。这种转变要求企业从产品思维转向用 ...

Core Points - The Guangxi Activity Week at the China Pavilion during the 2025 Osaka Expo will take place from June 11 to 13, with the theme "Beautiful Guangxi, Green Future" [1][2] - The event will feature a series of activities categorized as "4+3+N," including an opening ceremony, exhibitions, intangible cultural heritage performances, and cultural shows, aimed at showcasing Guangxi's achievements and promoting economic and cultural exchanges globally [1][2] Group 1 - The "Encountering Unique Guangxi" section will host the "Green · Coexistence · Towards the Future" exhibition, utilizing a combination of physical and digital technologies to highlight Guangxi's natural resources, ecological environment, and cultural heritage [1][2] - Featured products will include Guangxi's traditional items such as Zhuang brocade, Ni Xing pottery, and Liu Bao tea, alongside immersive projects like digital avatars and VR experiences to attract international visitors [1][2] Group 2 - The "Understanding Opportunities in Guangxi" section will leverage the Expo platform to showcase Guangxi's specialty products and facilitate business negotiations between Chinese and Japanese enterprises, focusing on ecological, energy, and health industries [2] - The "Spreading the Beauty of Guangxi" section will employ diverse media strategies to present Guangxi's ecological charm and cultural depth, integrating modern technology with traditional heritage for an immersive experience [2]

Core Viewpoint - In 2024, Dongfang Chuangye (600278) reported a total operating revenue of 35.429 billion yuan, a year-on-year increase of 5.30%, while the net profit attributable to shareholders decreased by 20.53% to 216 million yuan [2][3]. Financial Performance - The total operating revenue for 2024 was 35.429 billion yuan, up 5.30% from 2023 [2][3]. - The net profit attributable to shareholders was 216 million yuan, down 20.53% from the previous year [2][3]. - The net profit after deducting non-recurring gains and losses was 115 million yuan, a decrease of 23.14% year-on-year [2][3]. - The net cash flow from operating activities was -212 million yuan, compared to 312 million yuan in the same period last year [2][3]. - Basic earnings per share for 2024 were 0.25 yuan, with a weighted average return on equity of 2.91% [2][3]. Dividend Distribution - The company proposed a dividend distribution plan of 0.74 yuan per 10 shares (including tax) for all shareholders [2]. Non-Recurring Gains and Losses - The total non-recurring gains and losses amounted to 102 million yuan, with fair value changes and disposal gains from financial assets and liabilities contributing 99.49 million yuan [2]. Asset and Liability Changes - As of the end of 2024, accounts receivable increased by 40.59%, while cash and cash equivalents decreased by 6.98% [46][49]. - The company's total liabilities saw a significant increase, with accounts payable rising by 35.76% and short-term borrowings increasing by 64.83% [49]. Research and Development - The R&D expenditure for 2024 was 15.97 million yuan, a year-on-year increase of 98.31%, representing 0.05% of operating revenue [52]. Shareholder Structure - The top ten shareholders included new entrants Jinlongxing and Hu Xiaofeng, replacing previous shareholders [61].

Core Insights - The company reported a revenue of 35.429 billion yuan in 2024, marking a year-on-year increase of 5.30%, but the net profit decreased by 20.53% to 216 million yuan, indicating insufficient profitability in a complex market environment [1][4][5] Revenue Growth Concerns - The revenue growth to 35.429 billion yuan in 2024 is a recovery from 33.647 billion yuan in 2023, but it did not translate into profit growth, with a decline in gross profit to 1.678 billion yuan and a drop in gross margin from 5.26% to 4.74% [4] - Historical revenue growth has been unstable, with a decline of 18.88% in 2023 and 4.75% in 2022, reflecting a weak competitive position in the market [4] Profitability Issues - The net profit for 2024 was 216 million yuan, down 20.53%, marking the third consecutive year of decline, with previous decreases of 26.36% in 2023 and 2.95% in 2022 [5] - The net profit margin fell to 0.61% in 2024 from 0.81% in 2023, significantly below the industry average, indicating challenges in cost control and operational efficiency [5] - The net cash flow from operating activities was -212 million yuan, a decline of 167.92%, worsening the company's financial pressure [5] Business Segment Challenges and Opportunities - The three core business segments—goods trade, modern logistics, and health industry—maintained stable development in 2024, but each faced varying challenges [6] - In the goods trade segment, despite efforts to diversify markets, traditional market demand remained weak, leading to sluggish growth [6] - The modern logistics segment maintained stable profitability, but increased volatility in the shipping market raised operational risks [6] - The health segment improved customer loyalty through service optimization, but faced intense competition and limited profit margins [6] - The company implemented "internationalization" and "dual circulation" strategies to enhance core competitiveness, with total assets reaching 18.817 billion yuan and a debt-to-asset ratio of 57.98%, an increase of 2.84 percentage points from the previous year [6]